IGF1 and hyperlipidemia: In contrast to the C57BL/6 mouse model of HFD feeding in which NASH was associated with obesity, T2DM, and hyperlipidemia [38,39], the serological profile in the present model provided minimal evidence of hepatic insulin/IGF resistance.